UK CMO UK rejects review findings for non-applicability of evidence

Announcement Date: October 20, 2014

Public Accounts Committee Oral evidence: Tamiflu Recall, HC 677. Monday 20 October 2014

Public Accounts Committee Oral evidence : Tamiflu Recall, HC 677. Monday 20 October 2014

Inquiry: Tamiflu recall

5.00pm: Una O’Brien, Permanent Secretary, Department of Health Professor Dame Sally Davies, Chief Medical Office,
Department of Health

Sir Andrew Dillon, Chief Executive, National Institute for Health and Care Excellence

Dr Ian Hudson, Chief Executive, Medicines and Healthcare Products Regulatory Agency

Professor Carl Heneghan, Director, Centre for Evidence-based Medicine, University of Oxford

Dr Fiona Godlee, EditorinChief, British Medical Journal

33. Public Accounts Committee report: Access to clinical trial information and the stockpiling of Tamiflu

34. 20 Oct 2014 Tamiflu Recall oral evidence | PDF version ( 200 KB) HC 677 | Published 21 Oct 2014

35. 20 Oct 2014 Tamiflu Recall oral evidence | PDF version ( 200 KB) HC 677 | Published 28 Oct 2014